B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) Antibody
325€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx103991
Tested Applications
IHC
Description
Polyclonal Antibody to B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2).
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Primary Antibodies |
| Immunogen Target | Target: B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) Immunogen: Bcl2L2 (Arg11-Arg171) |
| Host | Rabbit |
| Reactivity | Dog |
| Recommended Dilution | WB (Predicted): 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Size 1 | 100 µl |
| Size 2 | 200 µl |
| Size 3 | 1 ml |
| Form | Liquid |
| Tested Applications | IHC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-7 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Alias | Bcl-2-like protein 2,BCLW,BCL-W,PPP1R51,BCL2-L-2,Apoptosis regulator Bcl-W |
| Background | Antibody anti-BCL2L2 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Background
BCL2 like 2 (BCL2L2), also known as BCL-W, is another anti-apoptotic protein in the Bcl-2 family, crucial for regulating cell survival by preventing mitochondrial apoptosis BCL2L2 interacts with pro-apoptotic proteins such as Bax and Bak, preventing their activation and the subsequent release of cytochrome c from the mitochondria BCL2L2’s role in inhibiting apoptosis is particularly important in cells that undergo high levels of stress, such as hematopoietic cells and certain neuronal populations Dysregulation of BCL2L2 has been associated with cancer, where its overexpression allows tumor cells to evade apoptosis, contributing to tumor survival, metastasis, and resistance to chemotherapy In addition, BCL2L2 is involved in maintaining tissue homeostasis and immune cell survival, influencing T-cell differentiation and activation Studies have suggested that BCL2L2 could be targeted for therapeutic purposes in both cancer and autoimmune diseases, where modulating cell death pathways can improve patient outcomes
Productos relacionados
B-Cell CLL/Lymphoma 2 Like Protein 2 (BCL2L2) Antibody
BCL2L2 Antibody is a Rabbit Polyclonal antibody against BCL2L2. This gene encodes a member of the BCL-2 protein family. …
Ver producto
B-Cell CLL/Lymphoma 2 Like Protein 2 (BCL2L2) Antibody
Rabbit Polyclonal against the BCL2L2 protein.…
Ver producto B-Cell CLL/Lymphoma 2 Like Protein 2 (BCL2L2) Antibody
Rabbit Polyclonal against the BCL2L2 protein.…
Ver producto